45786 Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices 

Drug Schedule 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

Oxymorphone (9652) ................... II 

Alfentanil (9737) ........................... II 

Remifentanil (9739) ...................... II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................ II 

The company plans on manufacturing 

the listed controlled substances in bulk 

for sale to its customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than October 6, 2008. 

Dated: July 30, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–18047 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated April 9, 2008, and 

published in the Federal Register on 

April 16, 2008, (73 FR 20718), Aldrich 

Chemical Company, Inc., DBA Isotec, 

3858 Benner Road, Miamisburg, Ohio 

45342–4304, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedules I and II: 

Drug Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) ................... I 

N-Ethylamphetamine (1475) ......... I 

N,N-Dimethylamphetamine (1480) I 

Aminorex (1585) ........................... I 

Gamma Hydroxybutyric Acid 

(2010).

I 

Methaqualone (2565) .................... I 

Ibogaine (7260) ............................. I 

Drug Schedule 

Lysergic acid diethylamide (7315) I 

Tetrahydrocannabinols (7370) ...... I 

Mescaline (7381) .......................... I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3,4-Methylenedioxy-methamphetamine (7405).I 

4-Methoxyamphetamine (7411) .... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

N-Ethyl-1-phenylcyclohexylamine 

(7455).

I 

Dihydromorphine (9145) ............... I 

Normorphine (9313) ...................... I 

Acetylmethadol (9601) .................. I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Normethadone (9635) ................... I 

Norpipanone (9636) ...................... I 

3-Methylfentanyl (9813) ................ I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............. II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

1-Phenylcyclohexylamine (7460) .. II 

Phencyclidine (7471) .................... II 

Phenylacetone (8501) ................... II 

1- 

Piperidinocyclohexanecarbonitrile (8603).

II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................. II 

Benzoylecgonine (9180) ............... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Isomethadone (9226) .................... II 

Meperidine (9230) ......................... II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Dextropropoxyphene, bulk, (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) .................... II 

Fentanyl (9801) ............................. II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to produce isotope labeled 

standards for drug testing and analysis. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Aldrich Chemical Company to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated Aldrich Chemical Company 

to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: July 29, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–17956 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated February 12, 2008 

and published in the Federal Register 

on February 21, 2008, (73 FR 9593), 

Roche Diagnostics Operations, Inc., 

Attn: Regulatory Compliance, 9115 

Hague Road, Indianapolis, Indiana 

46250, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Lysergic acid diethylamide (7315) I 

Tetrahydrocannabinols (THC) 

(7370).

I 

Alphamethadol (9605) .................. I 

Hydromorphone (9150) ................. II 

Benzoylecgonine (9180) ............... II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to manufacture 

small quantities of the listed controlled 

substances for use in diagnostic 

products. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Roche Diagnostics Operations, Inc. to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated Roche Diagnostics 

Operations, Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

mstockstill on PROD1PC66 with NOTICES